Abstract:In effort s to achieve minimal systemic toxicity and high tumor delivery efficiencies in cancer therapy, various nanomedicine formulations having stealth polymer coatings have been developed for minimizing immune cell uptake and off-target macrophage phagocyte system (MPS) organ accumulation. Despite an initial reduction in immune cell uptake, stealth nanoparticles still initiate an antibody immune response. This response acts on subsequent administrations in treatment regimens resulting in accelerated blood clearance of particles into MPS organs, particularly the liver, where they are retained for prolonged periods. Consequently, doses after the first administration in treatment regimens have diminished tumor accumulation and increased MPS toxicity. Here, we present a strategy reducing antibody responses to each dose in a treatment regimen by alternating between polyethylene-glycol and polymethyloxazoline polymers as the nanoparticle coating between administrations. In a weekly dosing regimen, we find that the first dose of particles having either coating display similar favorable pharmacokinetics and biodistributions, thus allowing the polymers to be used interchangeably. However, when maintaining the same coating in subsequent administrations, we find that particles are in circulation at the height of the antibody immune response resulting in 50-60% decreases of circulation half-lives and tumor accumulation along with 50% increases in liver accumulation. By alternating the polymers used in the nanoparticle coating between administrations, we find each dose maintains favorable in vivo behaviors at the height of the antibody immune response to the previous administration. Furthermore, our strategy increases the clearance of particles uptaken by macrophages and hepatocytes, resulting in marked decreases in hepatotoxicity. Statement of significance While nanoparticles with coatings consisting of stealth polymers can minimize immune cell uptake, they still initiate antibody immune responses leading to rapid blood clearance and MPS sequestration of subsequent administrations within a treatment regimen. We demonstrate that by alternating PEG and PMOZ polymer coatings between weekly administrations, the antibody immune response acting on each administration is minimal, and the favorable in vivo behaviors observed with the first administration is maintained in subsequent administrations. In this case, greater tumor accumulation is achieved while curtailing excessive MPS organ accumulation and toxicity throughout a nanomedicine treatment. We envision our strategy will benefit clinical trials where frequent administrations of therapeutics are required or in sequential deliveries of prognostic and therapeutic agents. (c) 2021 Published by Elsevier Ltd on behalf of Acta Materialia Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

A Stealthiness Evaluation of Main Chain Carboxybetaine Polymer Modified into Liposome

A bioinspired phospholipid polymer as drug-laden coating for biomedical device

Functional poly(dimethyl aminoethyl methacrylate) by combination of radical ring-opening polymerization and click chemistry for biomedical applications

Impact of spontaneous liposome modification with phospholipid polymer-lipid conjugates on protein interactions

Degradable and Tunable Supramolecular Polymer Micelles for Drug Delivery.

Diversely Substituted Poly( N -Vinyl Amide) Derivatives towards Non-Toxic, Stealth and pH-Responsive Lipid Nanocapsules

Synthesis and Application of Methoxy Poly(ethylene Glycol)‐bile Salts Conjugates in Physicochemical Characterization and the Pharmacokinetics of the Liposomal Bifendate in Rats

In depth study of the polydopamine coating of liposomes as a potential alternative to PEGylation for the stabilization of nanocarriers in biological fluids

Poly(carboxybetaine) Nanomaterials Enable Long Circulation and Prevent Polymer-Specific Antibody Production

Polymeric micelles with α-glutamyl-terminated PEG shells show low non-specific protein adsorption and a prolonged in vivo circulation time

Templated Polymer Replica Nanoparticles To Facilitate Assessment Of Material-Dependent Pharmacokinetics And Biodistribution

Methacrylic acid-co-butylmethacrylate copolymers: design, characterization and evaluation as encapsulating material for colon targeted formulations

Anchoring Property of a Novel Hydrophilic Lipopolymer, HDAS-SHP, Post-Inserted in Preformed Liposomes

Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; the Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity

Body Distribution and in Situ Evading of Phagocytic Uptake by Macrophages of Long-Circulating Poly (ethylene Glycol) Cyanoacrylate-Co-n-hexadecyl Cyanoacrylate Nanoparticles.

Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways

Stability Enhancement by Hydrophobic Anchoring and a Cross-Linked Structure of a Phospholipid Copolymer Film for Medical Devices

Alternating Stealth Polymer Coatings Between Administrations Minimizes Toxic and Antibody Immune Responses Towards Nanomedicine Treatment Regimens.

Stable, Bioresponsive, and Macrophage-Evading Polyurethane Micelles Containing an Anionic Tripeptide Chain Extender

Fabrication of Robust Biomimetic Coating by Integrated Physisorption/chemical Crosslinking Technique

Long in Vivo Circulating Nanomicelles Formed by Sharp-Contrast Janus Star Polymers Derived from Β-Cyclodextrin Grafted with Lipids and Polyzwitterions